-
Hospira Inc. v. Amneal Pharmaceuticals LLC DC CAFC
- 1:15-cv-00697
- D. Del.
- Judge: Richard G. Andrews
- Filed: 08/11/2015
- Closed: 02/06/2018
- Latest Docket Entry: 02/05/2020
- PACER
1
Plaintiff
1
Defendant
1
Accused
Product
4
Patents-in-Suit
911
Days in
Litigation
-
Hospira Inc. v. Amneal Pharmaceuticals LLC DC CAFC
- 1:15-cv-00697
- D. Del.
- Judge: Richard G. Andrews
- Filed: 08/11/2015
- Closed: 02/06/2018
- Latest Docket Entry: 02/05/2020
- PACER
Market Sector
Biotech and Pharma
Court
Assigned Judge
Outcome Summary
- Patent Information
-
Validity & Enforceability
| Claim # | Claim Text | Outcome |
|---|---|---|
| 3 |
The ready to use liquid pharmaceutical composition of claim 2, wherein the sodium chloride is present at a concentration of about 0.9 weight percent.
|
Invalid (102 and 103)
Entry 121 Entry 119 |
| 4 |
The ready to use liquid pharmaceutical composition of claim 1, wherein the composition is formulated as a total volume selected from the group consisting of 20 mL, 50 mL and 100 mL.
|
Invalid
Entry 121 |
-
Infringement
Amneal Pharmaceuticals, LLC
- 1 Detail
| Accused Product | Patent # | Claim # | Outcome |
|---|---|---|---|
| Hospira's 4µg/mL dexmedetomidine products ("Precedex premix") 100 mL glassvialsHospira's 4µg/mL dexmedetomidine products ("Precedex premix") in 50 mL glassvials | US 8,648,106 B2 |
6
|
Infringement
Entry 119
|
